Endo International | ENDP - Stock


Endo International reported $274.5M in Stock for its fiscal quarter ending in December of 2022.



Stock Change Date
AbbVie USD 5.05B 98M Mar/2026
Amarin USD 183.58M 12.32M Mar/2026
ANI Pharmaceuticals USD 143.47M 401K Mar/2026
Bristol-Myers Squibb USD 2.76B 66M Mar/2026
Coherus Biosciences USD 3.17M 1.12M Dec/2025
Eli Lilly USD 14.53B 785M Mar/2026
Heron Therapeutics USD 54.57M 2.33M Dec/2022
Hikma Pharmaceutical USD 1.08B 96M Jun/2025
Ligand Pharmaceuticals USD 13.27M 4.14M Mar/2026
Merck USD 6.48B 179M Mar/2026
Novartis USD 6.29B 17M Mar/2026
Pacira USD 150.37M 2.49M Mar/2026
Perrigo USD 1.12B 27.6M Mar/2026
Pfizer USD 10.67B 13M Mar/2026
Phibro Animal Health USD 539.7M 22.35M Mar/2026
Supernus Pharmaceuticals USD 110.77M 1.71M Mar/2026
Takeda JPY 1.41T 107.71B Dec/2025
Teva Pharmaceutical Industries USD 3.18B 144M Dec/2025
Xeris Pharmaceuticals USD 74.23M 5.56M Mar/2026
Zoetis USD 2.55B 120M Mar/2026